The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 379.00
Bid: 379.00
Ask: 380.00
Change: 1.00 (0.26%)
Spread: 1.00 (0.264%)
Open: 392.00
High: 392.00
Low: 376.00
Prev. Close: 378.00
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition update

9 Nov 2020 07:00

RNS Number : 5879E
Breedon Group PLC
09 November 2020
 

9 November 2020

 

Breedon Group plc

("Breedon" or the "Company")

 

Update on the acquisition of certain assets and operations

of CEMEX in the UK

 

Further to the announcement made on 10 September 2020, Breedon is pleased to announce that it has agreed the disposal of certain assets to Tillicoultry Quarries Limited for £12.2 million on a cash and debt free basis.

The 14 sites to be divested include 10 ready-mixed concrete plants and an asphalt plant and associated aggregates depot in England, and two quarries and a cement terminal in Scotland. The earnings of the assets being disposed of are not material to the Breedon Group.

Breedon is divesting these assets at the direction of the Competition and Markets Authority ("CMA") in order to address the CMA's concerns that Breedon's purchase of certain assets from Cemex Investments Limited ("CEMEX UK") gives rise to a realistic prospect of a substantial lessening of competition in certain areas. Completion of the disposal is subject to final confirmation by the CMA, following a public consultation inviting interested parties to submit their views, that it will accept the undertakings offered by Breedon in lieu of a Phase 2 reference and the approval of Tillicoultry Quarries Limited as a purchaser for the assets. The CMA intends shortly to launch the public consultation. The Company expects to be in a position to complete the disposal before the year end. Following completion of this disposal, the Group will integrate the remaining former CEMEX UK assets into its existing operations and implement its plans for performance improvement to deliver value from the acquisition.

 

Commenting on today's announcement Pat Ward, Breedon's Group Chief Executive, said:

"We are very pleased with the outcome of this process and believe it is in the interests all stakeholders.

"It allows Breedon to realise fair value for the assets disposed of which, together with the people employed in them, will be in good hands under new ownership of Tillicoultry Quarries."

- ends -

Information on Breedon Group

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. Following the acquisition of CEMEX's UK Assets (and subject to the remedies required by the CMA), the Group employs over 3,500 people and has around 1 billion tonnes of mineral reserves and resources. The Group's strategy is to continue growing through organic improvement and the acquisition of businesses in the heavyside construction materials market.

Enquiries:

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director

Stephen Jacobs, Group Head of Communications

 

Cenkos Securities (NOMAD and Joint Broker to Breedon)

Max Hartley

Harry Hargreaves

 

Numis Securities (Joint Broker to Breedon)

Ben Stoop

Heraclis Economides

 

Teneo (Public Relations Adviser to Breedon)

Matt Denham

Rachel Miller

 

 

 

01332 694010

 

 

07831 764592

 

020 7397 8900

 

 

 

020 7260 1000

 

 

 

020 7420 3180

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEVLFBBFLXFBV
Date   Source Headline
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.